InvestorsHub Logo
Followers 30
Posts 1939
Boards Moderated 0
Alias Born 01/11/2011

Re: Sam81 post# 206517

Thursday, 08/08/2019 8:30:42 AM

Thursday, August 08, 2019 8:30:42 AM

Post# of 425933
https://www.newswire.ca/news-releases/hls-therapeutics-announces-q2-2019-financial-results-818092816.html

We believe Vascepa has the potential to transform our business and have conservatively estimated its potential peak revenue range at C$150-250 million, should it achieve regulatory approval. With its Priority Review underway, we expect to receive Health Canada's response toward the end of Q4 2019."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News